Search For "icmr director"
Lucknow man alleges no antibodies developed after taking Covishield shot,
Updated : 5 years ago IST
Lucknow (Uttar Pradesh) [India], May 31 (ANI): A man from Lucknow has filed a police complaint against Serum Institute of India CEO Adar Poonawalla, ICMR director-general Dr Balram Bhargava and others on Tuesday alleging that no antibodies against COVID-19 were developed in his body despi
Read More
COVID self-testing kits to be available in 3-4 days, says ICMR DG
Updated : 5 years ago IST
New Delhi [India], May 20 (ANI): Home self-testing kits intended to detect COVID-19 infection will be available in the market in the next three to four days, ICMR Director-General Balram Bhargava said on Thursday.
Read More
Oxygen utilization more in second wave of COVID-19, says ICMR DG
Updated : 5 years, 1 month ago IST
New Delhi [India], April 19 (ANI): ICMR Director General Dr Balram Bhargava has said that oxygen utilization has been more in the second wave of COVID-19.
Read More
Emergency use of vaccine is based on safety, immunogenicity data, says ICM
Updated : 5 years, 5 months ago IST
New Delhi [India], January 5 (ANI): The Indian Council of Medical Research (ICMR) director Dr Balram Bhargava on Tuesday said that in a pandemic situation, restricted emergency use of the vaccine is considered based on phase 2 safety and immunogenicity clinical trial data while phase thre
Read More
Non-judicious use of therapies for COVID-19 leads to virus mutations: ICMR
Updated : 5 years, 5 months ago IST
New Delhi [India], December 29 (ANI): Non-judicious use of therapies that have not been established for COVID-19 treatment are responsible for putting "immune pressure on virus" and leads to virus mutations, ICMR Director-General Dr Balram Bhargava said on Tuesday.
Read More
`Adverse event' has not affected timelines of COVID-19 vaccine trial: Heal
Updated : 5 years, 6 months ago IST
New Delhi [India], December 2 (ANI): Health Secretary Rajesh Bhushan said on Tuesday that "adverse event" related to vaccine trial participant in Chennai will not affect the timelines and noted that a trial site has an institutional ethics committee which is independent of the manufacture
Read More
COVID-19 re-infection possible if antibodies in recovered person reduce wi
Updated : 5 years, 7 months ago IST
New Delhi [India], October 20 (ANI): There is a possibility of re-infection, if antibodies reduce in the body of a Covid-19 recovered person in five months time after the recovery, the Indian Council of Medical Research (ICMR) Director-General Dr Balram Bhargava said on Tuesday.
Read More
India's COVID-19 testing capacity 10 lakh per day through 1,524 labs: ICMR
Updated : 5 years, 9 months ago IST
New Delhi [India], Aug 25 (ANI): India's testing capacity has increased significantly from 10 tests to 10 lakh tests per day and all ministries have worked to achieve this, ICMR Director General Balram Bhargava said on Tuesday.
Read More
COVID-19: Union Health Secy, ICMR ask states, UTs to ramp up testing capac
Updated : 5 years, 10 months ago IST
New Delhi [India], July 21 (ANI): Union Health Secretary Preeti Sudan and Indian Council of Medical Research (ICMR) Director-General, Dr Balram Bhargava, have written to all states and union territories (UTs) to ramp up COVID-19 testing capacity.
Read More
Decided not to deny health workers HCQ based on risk-benefit analysis: ICM
Updated : 6 years ago IST
New Delhi [India], May 26 (ANI): Noting that a lot of drugs are being repurposed for treatment of COVID-19, ICMR Director-General Dr Balram Bhargava on Tuesday said that prophylactic use of Hydroxychloroquine (HCQ) for health care workers had been recommended on the basis of risk-benefit a
Read More
India testing 1.1 lakh COVID-19 samples in a day: ICMR chief
Updated : 6 years ago IST
New Delhi [India], May 26 (ANI): India is testing about 1.1 lakh COVID-19 samples in a day at 612 labs, ICMR Director-General Dr Balram Bhargava said on Tuesday.
Read More
India can easily do synthesis of antiviral drug - Remdesivir: Former ICMR
Updated : 6 years, 1 month ago IST
New Delhi [India], May 3 (ANI): India can easily do the synthesis of antiviral drug - Remdesivir - if allowed by the US-based pharma major Gilead Sciences, said Dr Nirmal K Ganguly, former Director-General, Indian Council of Medical Research (ICMR), on Saturday.
Read More